{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:16:22Z","timestamp":1707524182696},"reference-count":13,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,30]]},"DOI":"10.7759\/cureus.12377","type":"journal-article","created":{"date-parts":[[2020,12,30]],"date-time":"2020-12-30T14:09:27Z","timestamp":1609337367000},"source":"Crossref","is-referenced-by-count":0,"title":["Persistent Immune Thrombocytopenia Resistant to Immunosuppressive Therapy: What Is the Way Forward?"],"prefix":"10.7759","author":[{"given":"Muhammad Hafiz","family":"Kamarul Bahrin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harini","family":"Vijayenthiran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Stimson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Humayun","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1080\/20009666.2019.1565884","article-title":"Immune thrombocytopenic purpura","volume":"9","author":"Zainal A","year":"2019","unstructured":"Zainal A, Salama A, Alweis R. Immune thrombocytopenic purpura. J Community Hosp Intern Med Perspect. 2019, 9:59-61. 10.1080\/20009666.2019.1565884","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"ref2","article-title":"Case review: idiopathic thrombocytopenic purpura","volume":"3","author":"Cohen R","year":"2012","unstructured":"Cohen R, Garcia C, Mena D, Castellanos M, Wu L-T. Case review: idiopathic thrombocytopenic purpura. J Med Cases. 2012, 3:130-134.","journal-title":"J Med Cases"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1054\/blre.2001.0169","article-title":"Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura","volume":"16","author":"McFarland J","year":"2002","unstructured":"McFarland J . Pathophysiology of platelet destruction in immune (idiopathic) thrombocytopenic purpura. Blood Rev. 2002, 16:1-2. 10.1054\/blre.2001.0169","journal-title":"Blood Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.12703\/P6-45","article-title":"Management of thrombocytopenia","volume":"6","author":"Izak M","year":"2014","unstructured":"Izak M, Bussel JB. Management of thrombocytopenia. Faculty Opinions. 2014, 6:45. 10.12703\/P6-45","journal-title":"Faculty Opinions"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/HMER.S74612","article-title":"The pathophysiology of thrombocytopenia in chronic liver disease","volume":"8","author":"Mitchell O","year":"2016","unstructured":"Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med. 2016, 8:39-50. 10.2147\/HMER.S74612","journal-title":"Hepat Med"},{"key":"ref6","doi-asserted-by":"crossref","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes PJ","year":"2006","unstructured":"Barnes PJ. How corticosteroids control inflammation: quintiles prize lecture 2005. Br J Pharmacol. 2006, 148:245-254.","journal-title":"Br J Pharmacol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2344\/0003-3006-60.1.25","article-title":"Basic and clinical pharmacology of glucocorticosteroids","volume":"60","author":"Becker DE","year":"2013","unstructured":"Becker DE. Basic and clinical pharmacology of glucocorticosteroids. Anesth Prog. 2013, 60:25-32. 10.2344\/0003-3006-60.1.25","journal-title":"Anesth Prog"},{"key":"ref8","unstructured":"Immune (idiopathic) thrombocytopenic purpura. rituximab. (2014). Accessed: 12\/12\/2020: https:\/\/www.nice.org.uk\/advice\/esuom35\/chapter\/Key-points-from-the-evidence."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1080\/10245332.2016.1219497","article-title":"Advances in the pathophysiology of primary immune thrombocytopenia","volume":"22","author":"Perera M","year":"2017","unstructured":"Perera M, Garrido T. Advances in the pathophysiology of primary immune thrombocytopenia. Hematology. 2017, 22:41-53. 10.1080\/10245332.2016.1219497","journal-title":"Hematology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1177\/2040620712453596","article-title":"The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia","volume":"3","author":"Cooper N","year":"2012","unstructured":"Cooper N, Terrinoni I, Newland A. The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia. Ther Adv Hematol. 2012, 3:291-298. 10.1177\/2040620712453596","journal-title":"Ther Adv Hematol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-742353","article-title":"Splenectomy for immune thrombocytopenia: down but not out","volume":"131","author":"Chaturvedi S","year":"2018","unstructured":"Chaturvedi S, Arnold DM, McCrae KR. Splenectomy for immune thrombocytopenia: down but not out. Blood. 2018, 131:1172-1182. 10.1182\/blood-2017-09-742353","journal-title":"Blood"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.210252","article-title":"Reactivation of hepatitis B virus infection in patients with hematologic disorders","volume":"104","author":"Wang B","year":"2019","unstructured":"Wang B, Mufti G, Agarwal K. Reactivation of hepatitis B virus infection in patients with hematologic disorders. Haematologica. 2019, 104:435-443. 10.3324\/haematol.2018.210252","journal-title":"Haematologica"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1159\/000481617","article-title":"Immune thrombocytopenia as a consequence of rocky mountain spotted fever","volume":"10","author":"Baldeo C","year":"2017","unstructured":"Baldeo C, Seegobin K, Zuberi L. Immune thrombocytopenia as a consequence of rocky mountain spotted fever. Case Rep Oncol. 2017, 10:945-947. 10.1159\/000481617","journal-title":"Case Rep Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/43375-persistent-immune-thrombocytopenia-resistant-to-immunosuppressive-therapy-what-is-the-way-forward","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:22:16Z","timestamp":1707506536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/43375-persistent-immune-thrombocytopenia-resistant-to-immunosuppressive-therapy-what-is-the-way-forward"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,30]]},"references-count":13,"URL":"https:\/\/doi.org\/10.7759\/cureus.12377","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,30]]}}}